Showing results (371-380 of 700) with videos related to

Sort By:
Pageof 70
JAMA Network Open|August 5, 2025
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance ExpansionMattia A Mahmoud, Sarah Ehsan, Sara P Ginzberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinicHelen A Shih, Fergus J Couch, Katherine L Nathanson, et al.
Cancer Research|August 27, 2009
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688delArcangela De Nicolo, Emilio Parisini, Quan Zhong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Correlation of somatic mutations and clinical outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenibMelissa A Wilson, Fengmin Zhao, Richard Letrero, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
A Thiopurine-like Mutagenic Process Defines TGCT SubtypesKevin M Brown, Jun Zhong, Adriana Morales Miranda, et al.
BMC Public Health|May 13, 2021
HIV treatment engagement in the context of COVID-19: an observational global sample of transgender and nonbinary people living with HIVArjee Javellana Restar, Henri M Garrison-Desany, Tyler Adamson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer RiskAnita Villani, Mary-Louise C Greer, Jennifer M Kalish, et al.
Plos One|March 26, 2013
The anti-melanoma activity of dinaciclib, a cyclin-dependent kinase inhibitor, is dependent on p53 signalingBrijal M Desai, Jessie Villanueva, Thierry-Thien K Nguyen, et al.
JAMA Network Open|December 15, 2025
Genomic Ascertainment of CHEK2-Related Cancer PredispositionSun Young Kim, Jung Kim, Mark Ramos, et al.
JCO Oncology Practice|July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic AdenocarcinomaKelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.
Pageof 70